Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of OCT1 Genotype and OCT1 Inhibiting Drugs on an Individual's Tolerance of Metformin

NCT02586636 is registered in ClinicalTrials.gov with NHS Tayside as lead sponsor.

NCT NCT02586636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of OCT1 Genotype and OCT1 Inhibiting Drugs on an Individual's Tolerance of Metformin
Lead sponsor
NHS Tayside
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
April 9, 2018
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tolerance